TearLab (TEAR)

Add to Watchlists
Create an Alert
4.63 -0.35  -7.03% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
TEAR Price Chart
View All Events

TEAR Events

Date Type Description
Mar 13 Misc TearLab Corpoartion Q4 2013 Earnings Conference Call
Mar 13 Earnings TearLab Corpoartion Q4 2013 Earnings Results. Estimate: -0.13.
Feb 18 Misc TearLab to Acquire Aoa's Ocuhub Technology Platform
Nov 12 Misc San Diego Earnings Conference Call Dur
Nov 12 Earnings San Diego Earnings Results. Estimate: -0.14.
Aug 13 Misc TearLab Announces Q2 2013 Financial Conference Call
Aug 13 Earnings TearLab Corporation to Release Q2 2013 Financial Results on August 13, 2013. Estimate: -0.11.
Jun 07 Misc AGM Event for TearLab Corp
May 13 Misc TearLab First Quarter 2013 Earnings Call
May 13 Earnings TearLab Corporation to Release Q1 2013 Financial Results on May 13, 2013. Estimate: -0.12.
View All Performance Charts

TEAR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). TearLab is down 37.43% over the last year vs S&P 500 Total Return up 22.72%, Agilent Technologies up 30.81%, and Abaxis down 11.44%.

Get Quote for

Portfolio Strategies Featuring TEAR

Did TearLab make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

TEAR Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

TearLab Corp is an in-vitro diagnostic company. It commercializes a proprietary tear testing platform that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film.

Recent Quotes

Symbol Price Chg Chg % Market Cap
TEAR 4.63 -0.35 -7.03% 154.13M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.